TARCEVA
Identification of Tarceva
No description |
Google image searchProduct monograph
Active ingredient
erlotinib (erlotinib hydrochloride), 100 MG
DIN: 02269015
Dosage form(s): TABLET
Route(s) of administration: ORAL
Schedule: Prescription
Company: HOFFMANN-LA ROCHE LIMITED
Date: 19-JUL-2005
ATC:
- L01 — ANTINEOPLASTIC AGENTS (ATC, ATC/DDD, )
- L01E — PROTEIN KINASE INHIBITORS (ATC, ATC/DDD)
- L01EB — Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (ATC, ATC/DDD)
- L01EB02 — ERLOTINIB (ATC/DDD)
Reference brand drug: Tarceva
External Links for Tarceva
Search on Google
Hoffmann-La Roche Limited
Go to Hoffmann-La Roche website to see drug product details. Sometimes you can find tarceva photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.